Renatech Inc. (Headquarters: Isehara City, Kanagawa Prefecture), which builds health indicators based on trace elements and applies them to real-world situations, is pleased to announce that the "Metallo-Balance Test," a screening test developed and provided by the company to assess the risk of cancer and MCI (Mild Cognitive Impairment), will be newly offered starting August 2026 at three clinics operated by Jinngakkai Medical Corporation: Satomura Clinic, Satomura Gastroenterology and Endoscopy Clinic (Minami Ward), and Satomura Diabetes Clinic Aeon Town Higashi-Urawa Branch (Midori Ward).

With the addition of these three clinics, the testing system for the "Metallo-Balance Test" in the Saitama City area will be further expanded, providing local residents with a more accessible and new option for health management.

Our company will continue to partner with medical institutions nationwide to encourage more people to take an interest in their health status and to provide an opportunity to review their daily health management and lifestyle habits as a preventive measure against illness.

What is the Metallo-Balance (MB) Test?

This is a risk screening (sorting) test that objectively assesses the risk of cancer and MCI (Mild Cognitive Impairment) at the time of blood collection by analyzing the concentration balance of 17 types of trace elements (metal elements) in the blood.

【Features of this test】

Just one 6mL blood draw: Blood is collected safely under appropriate management systems at medical institutions. The test takes approximately 15 minutes, is short, and has minimal burden on the body, providing peace of mind.

Site-specific "Cancer Risk Test": A single blood draw assesses the risk of the following cancers by site (6 sites for men, 9 sites for women) and evaluates it on a 4-level scale from A to D. [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, uterine body cancer, ovarian cancer

Comprehensive "Cognitive Risk Test (MCI Risk Assessment)": Comprehensively assesses all types of cognitive impairment, not only Alzheimer's type but also vascular and Lewy body types.

Proven research results and international recognition: Developed with research grants from the Ministry of Economy, Trade and Industry's Go-Tech project and in joint research with Kanagawa Cancer Center and Chiba Cancer Center. Patents have been obtained in 9 countries worldwide, including Japan, and the cumulative number of examinees has exceeded 100,000 (actual results from April 2019 to March 2026).

Testing procedure and main precautions before testing

*Due to the need for mail processing of documents, advance applications are required approximately 3 weeks before the desired test date (reservations are strictly by appointment).

Application: Please apply via the web or by phone. Approximately one week before your reservation date, a set of examination documents will be delivered to your home.

Day of test (blood collection): As reservations are strictly by appointment, blood collection will proceed smoothly (approx. 15 minutes). Payment is made later, so no payment is required at the clinic counter on the day.

Result notification: The invoice (payment slip) will be mailed to your home approximately 3 weeks after blood collection, and the test results will be mailed approximately 5 weeks after blood collection.

【Main precautions before testing】

Food and drink: No food or drink after 9:00 PM the day before. No alcohol from the day before. Water: Please drink plenty of water to facilitate blood collection.

Medications and supplements: No over-the-counter medications or supplements from the day before. Prescription medications should be taken as usual.

Test fees (out-of-pocket medical expenses)

This test is not covered by health insurance and is considered out-of-pocket medical expenses. You can choose from the following courses according to your needs.

Cancer Risk Test: ¥19,800 (tax included)

Cognitive Risk Test: ¥19,800 (tax included)

Cancer and Cognitive Risk Test Set: ¥24,200 (tax included)

*Prices shown are standard prices. *Payment will be made via "DSK Post-payment" delivered to your home after blood collection. *Some medical institutions may not offer one of these tests.

Target individuals for the Metallo-Balance Test and precautions

【Regarding age】

Cancer Risk Test: Japanese individuals aged 20 to 80

Cognitive Risk Test: Japanese individuals aged 50 to 80

*This test was developed based on data from Japanese individuals within the above age ranges. Therefore, while individuals outside these age ranges or foreign nationals can take the test, the results will be considered "reference values" only. Please be aware of this in advance.

【The following individuals cannot take the test】

Pregnant women or those within 6 months of childbirth

Individuals undergoing cancer treatment or those who have completed cancer treatment less than 1 year ago

Individuals receiving dialysis

Individuals with fractures, blood disorders, or immunodeficiency (excluding dyslipidemia due to triglycerides, etc.)

Individuals who are unwell (lack of sleep, after staying up all night, immediately after strenuous exercise, under severe stress, or with symptoms such as colds, asthma, shingles, allergic rash/rhinitis, etc.)

Overview of new introducing medical institutions

Test start date: September 1, 2026 (Tue) Test hours: Monday to Saturday (excluding holidays and public holidays)

Medical Institution Name: Satomura Clinic

Location: 5320-1 Otoguchi, Minami-ku, Saitama City, Saitama Prefecture, 336-0042 🅿️Parking available 📍MAP

Access: ●Train: 15-minute walk from Higashi-Urawa Station on the JR Musashino Line ●Bus: Take the bus bound for "Midori Ward Office" (Higashi-Urawa 03) from the "Higashi-Urawa Station" bus stop and get off at "Higashi-Urawa Kominkan Iriguchi" bus stop (3 minutes walk).

Tests offered: Cancer Risk Test, Cognitive Risk Test

Test start date: August 25, 2026 (Tue) Test hours: Monday to Saturday (excluding holidays and public holidays)

Medical Institution Name: Satomura Gastroenterology and Endoscopy Clinic

Location: MID KUDOS TERRACE 5F, 5-18-19 Shirohata, Minami-ku, Saitama City, Saitama Prefecture, 336-0022 📍MAP

Access: ●Train: 1-minute walk from the East Exit of Musashi-Urawa Station on the JR Musashino Line and Saikyo Line.

Tests offered: Cancer Risk Test, Cognitive Risk Test

Test start date: August 27, 2026 (Thu) Test hours: Monday to Saturday (excluding holidays and public holidays)

Medical Institution Name: Satomura Diabetes Clinic Aeon Town Higashi-Urawa Branch

Location: Aeon Town Higashi-Urawa 4F, 1-1-6 Higashi-Urawa, Midori-ku, Saitama City, Saitama Prefecture, 336-0926 🅿️Parking available 📍MAP

Access: ●Train: 1-minute walk from Higashi-Urawa Station on the JR Musashino Line.

Tests offered: Cancer Risk Test, Cognitive Risk Test

⚠️ Important request regarding testing (please read carefully) Please refrain from contacting the medical institutions directly: The hospital counter and phone lines cannot handle inquiries or applications for this test. For inquiries or applications regarding the test, please contact Renatech.

For details and to apply for the test, click here

Metallo-Balance Test Information Site: https://www.mbkensa.com/

Dedicated toll-free number: 0120-785-602 (Renatech: Weekdays 9:00-17:00)

▼ Digital version of the Metallo-Balance Test leaflet

d182526-11-dee1ca95c1d38e1905bc5d6b14504f27.pdf

🏥 We are also recruiting partner medical institutions nationwide! Click here for information on introducing the Metallo-Balance Test.

Metallo-Balance Original Character: Metarona-chan

Renatech Inc. is an innovation company that develops unique technologies in the medical/health fields and environmental fields, aiming for early risk assessment of diseases such as cancer. The company has also been selected as one of the "300 Excellent Companies of Small and Medium Enterprises that are Making Strides" by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency, recognizing its excellent technological development and service provision, and its high technical capabilities and social contribution are acknowledged by the government.

Among these, the "Metallo-Balance Test" is attracting significant attention as a groundbreaking screening technology that assesses the risk of developing cancer and MCI (Mild Cognitive Impairment) by analyzing the concentration of 17 types of trace elements in the blood. Moving forward, our company will continue to create new value for the promotion of people's health and the resolution of social issues based on our advanced technological capabilities.

Company Profile ■

Company Name: Renatech Inc.

Representative: Kei Kato, Representative Director

Head Office Location: 4-19-15 Takamori, Isehara City, Kanagawa Prefecture, 259-1114

URL: https://www.renatech.net/

FACT BOX

  • Source: PR TIMES
  • Category: サービス開始